Botaniam Xtractx Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-07-2024
- Paid Up Capital ₹ 70.00 K
as on 03-07-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 55.53%
(FY 2022)
- Ebitda 88.85%
(FY 2022)
- Net Worth -45.55%
(FY 2022)
- Total Assets -35.44%
(FY 2022)
About Botaniam Xtractx
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 70.00 K , as per Ministry of Corporate Affairs (MCA) records.
Jacob Issac, Neelam Varghese, Ashok Mani, and Two other members serve as directors at the Company.
- CIN/LLPIN
U15490KL2020PLC064576
- Company No.
064576
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Botaniam Xtractx?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neelam Varghese  | Director | 23-Sep-2020 | Current |
| Joseph John | Director | 23-Sep-2020 | Current |
| Jacob Issac | Director | 23-Sep-2020 | Current |
| Ashok Mani | Director | 23-Sep-2020 | Current |
| Jacob Modayil | Director | 18-Dec-2020 | Current |
Financial Performance of Botaniam Xtractx.
Botaniam Xtractx Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 55.53% increase in profit. The company's net worth observed a substantial decline by a decrease of 45.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Botaniam Xtractx?
In 2021, Botaniam Xtractx had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symega Food Ingredients LimitedActive 18 years 5 monthsNeelam Varghese and Ashok Mani are mutual person
Synthite Industries Private LimitedActive 54 years 5 monthsAshok Mani and Jacob Modayil are mutual person
- Synthite Infrastructure Projects Private LimitedActive 4 years 7 months
Joseph John is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Botaniam Xtractx?
Botaniam Xtractx has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Botaniam Xtractx, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Botaniam Xtractx's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
